Faes FarmaFRA:FFEA -0.44%90 Beneish M-Score is -2.75 as of Jun. 28, 2026. GuruFocus rates FRA:FFEA with a GF Score™ of 90/100 and a GF Value™ of €5.02 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 908 Drug Manufacturers companies, Faes Farma ranks better than 71.59% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -2.75 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for Faes Farma's Beneish M-Score or its related term are showing as below:
FRA:FFEA'
s Beneish M-Score Range Over the Past 10 Years
Min: -2.75 Med: -2.51 Max: -2.3
Current: -2.75
During the past 13 years, the highest Beneish M-Score of Faes Farma was -2.30. The lowest was -2.75. And the median was -2.51.
Faes Farma Beneish M-Score Related Terms
Faes Farma Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Faes Farma's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:FFEA vs ZTS, UTHR, VTRS: Beneish M-Score Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma Beneish M-Score vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Faes Farma's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Faes Farma for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 1.1372
+
0.528 * 1.0199
+
0.404 * 1.4733
+
0.892 * 1.2366
+
0.115 * 0.8329
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 1.1274
+
4.679 * 0.00085
-
0.327 * 3.3714
=
-2.75
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(20.318 / (20.318 + 300.941))
/
(29.033 / (29.033 + 353.308))
=
0.063245
/
0.075935
=
0.8329
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(79.63 - 0
-
78.49)
/
1341.895
=
0.00085
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Faes Farma has a M-score of -2.75 suggests that the company is unlikely to be a manipulator.
Faes Farma (FRA:FFEA) has a Beneish M-Score of -2.75 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Faes Farma and its competitors. According to the industry distribution chart, Faes Farma ranks #258 out of 908 companies in the Drug Manufacturers industry, placing it in the top 28.4%.
Is Faes Farma's Beneish M-Score too high?
Faes Farma's current Beneish M-Score is -2.75. Based on the distribution chart, Faes Farma ranks #258 out of 908 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Faes Farma has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Faes Farma ranks #258 out of 908 companies for Beneish M-Score. This puts Faes Farma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Faes Farma and its competitors. Faes Farma's current Beneish M-Score is -2.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Based on GuruFocus' analysis, Faes Farma (FRA:FFEA) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.02, compared to a current price of €4.54 — trading 9.7% below its estimated fair value. The current Beneish M-Score is -2.75. Faes Farma's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Faes Farma (FRA:FFEA), the current Beneish M-Score is -2.75 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Faes Farma (FRA:FFEA) Overvalued in 2026?
Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued.
The current stock price of €4.54 is trading 9.7% below its estimated GF Value™ of €5.02.
GuruFocus considers Faes Farma to be Modestly Undervalued.
Key valuation signals for FRA:FFEA:
Beneish M-Score: -2.75
GF Value™: €5.02 vs. price of €4.54 (9.7% below fair value)
No single metric tells the full story. See the FRA:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
90GF Score
Get the complete analysis for FRA:FFEA
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FFEA has been successfully added to your 
